14. - 17.11.2017
Frankfurt am Main
formnext powered by tct 2017
International exhibition and conference on the next generation of manufacturing technologies

 
 
 

Session Healthcare - Stage 1

11:15 Manuel Opitz & Jannis Breuninger, Mecuris GmbH

Schedule

Wednesday, 15.11.2017, 11:15 - 11:45 hrs

Description

11:15 Up & Running: Performant Prosthetic thanks to Digital Tailoring & AM
Manuel Opitz, Mecuris GmbH, CEO, München, Deutschland
Jannis Breuninger, Mecuris GmbH, Head of Product Development, München, Deutschland
After orthopaedic care underwent progressive standardisation to the disadvantage of patients in the last decades, new additive manufacturing (AM) methods enable the re-individualisation of prostheses and orthoses once more. A remaining challenge for AM in orthopaedics represents the complexity of required applications and tools. Therefore, Mecuris is providing a digital process chain to design patient aids with automated adaption of a parametric CAD model to the patient's individual needs. In this talk, hear how Mecuris managed to introduce the world's first additive manufactured prosthetic foot with a CE mark in 2017.

Speakers

Herr Jannis Breuninger
Jannis Breuninger
Mecuris GmbH, Head of Product Development, München, Deutschland
Jannis Breuninger: Before co-founding Mecuris GmbH as Chief 3D-Design Officer, Jannis Breuninger researched design for additive manufacturing at Fraunhofer IPA, Stuttgart. He published a book on his findings in generative manufacturing and design with SLS (Springer 2013) and was part of the team that won the German Future Prize 2010 with its Bionic Handling Assistant. His academic background is both in Product Development (M.Sc. at HS Pforzheim) as well as industrial design (Dipl.-Des. at HS Schwäbisch-Gmünd). Jannis focuses on finding smart solutions for the design of prostheses and ortheses, so patients may benefit from a customised, lightweight design, an increased durability and - last but not least - a simply awesome new look.
Herr Manuel Opitz
Manuel Opitz
Mecuris GmbH, CEO, München, Deutschland
Manuel Opitz: Before co-founding Mecuris GmbH as a CEO, Manuel Opitz worked as an IP broker for medical patents, in innovation transfer & marketing at the leading supplier for SLS powder and as a technology scout in China. He has a dual academic background in both industrial engineering (M.Sc. at RWTH Aachen and Trinity College Dublin) as well as business administration (postgrad MBA at Collège des Ingénieurs, Paris). Manuel takes a key interest in analysing the process chains at CPOs and hospitals to identify areas, where it makes sense to use digital means like medical image processing or additive manufacturing to improve patient comfort and compliance as well as the user experience of the medical practitioner.


Back